Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
17-Jun-15 By 2030, Japan's healthcare costs could be 20% of GDP, experts say. The ageing population and a preference for hospital treatment add to an already overburdened system. The government has been studying wellness, disease prevention, treatment and early detection programs and a recent 'Health Policy White Paper 2015' recommends 200 policies “likely to yield significant positive potential impact”. [image: InterNations]Read More
30-Jun-15 SMalaysia's medical tourism industry continues to rake in more income for the country, with MYR1 bn (USD264 mn) expected in 2015. “Malaysia's share of the medical tourism market has nearly doubled in the last four years. In 2014, it reached 770,000 patients, bringing in revenue of around MYR700 mn,” said Prime Minister Datuk Seri Najib Tun Razak. [image: The Star]Read More
30-Jun-15 The Chinese government will support domestic hospitals in promoting Chinese medicine worldwide, the Overseas Chinese Affairs Office of the State Council has said. It is encouraging domestic hospitals to foster ties with hospitals in other counties run by overseas Chinese and to set up Chinese medicine centres abroad. [image: UPI / Stephen Shaver]Read More
China's huge healthcare market is seeing strong growth as health spending advances. The combination of urbanisation and improvements in rural areas is creating many opportunities. The ageing population is imposing increasing demands on an already stretched healthcare system, rapidly changing as healthcare reform continues, but more is needed to improve access and affordability. Request the free whitepaperRead More
28-Jun-15 As part of the Make in India strategy, India's government plans to set up a INR5 bn (USD79 mn) fund to boost the domestic pharma industry and provide cheaper loans for manufacturing. It is also considering single window clearance for drug approvals, to help rejuvenate the local pharma sector and make medicines more affordable. [image: ET Healthworld]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: